Module 8: Part 3 (53-79) Flashcards
Late asthmatic response (6)
Begins 4 to 8 hours after the early response
Chemotactic recruitment of lymphocytes, eosinophils, and neutrophils occurs
Air trapping
Hyperinflation distal to obstructions
Increased work of breathing
Hypoxemia
Chemotactic recruitment of lymphocytes, eosinophils, and neutrophils occurs in late asthmatic response causes… (5)
Prolonged smooth muscle contraction
Airway scarring
Increased bronchial hyperresponsiveness
Impaired mucociliary function with accumulation of mucous and cellular debris, forming plugs in the airways
Leads to airway remodeling if left untreated
clinical manifestations of asthma (8)
Asymptomatic between attacks
Chest constriction, expiratory wheezing, dyspnea, nonproductive coughing, prolonged expiration, tachycardia, tachypnea
Pulsus paradoxus
Status asthmaticus
Ominous signs of impending death
status asthmaticus
Bronchospasm not reversed by usual measures
Life threatening
What treatment is indicated for severe asthma and can potentially worsen asthma in some individuals?
Long-acting beta agonists
Ominous signs of impending death
Silent chest (no audible air movement) and a Paco2greater than 70 mm Hg
Asthma TX (5)
Immediate administration of O2 & inhaled beta-agonist bronchodilators
Oral corticosteroids administration early
Careful monitoring of gas exchange & airway obstruction in response to therapy
Antibiotics are not indicated for acute asthma unless a bacterial infection is documented
Education over allergens and irritants and peak flow meters
asthma Pharmacologic treatments (6)
Mildest form of asthma (intermittent): Short-acting beta-agonist inhalers
Persistent asthma: Antiinflammatory medications and inhaled corticosteroids—the mainstay of therapy
Not adequately controlled on inhaled corticosteroids: Leukotriene antagonists
Severe asthma: Long-acting beta agonists (can actually worsen asthma in some individuals)
Reduction of asthma exacerbations: Immunotherapy
Monoclonal antibodies to IgE
What are the ominous signs of impending death in status asthmaticus?
Silent chest (no audible air movement) and a PaCO2 greater than 70 mm Hg
Which medication is used as the mainstay of therapy for persistent asthma?
Inhaled corticosteroids
Airflow limitation that is not fully reversible
COPD
Usually progressive and a/w an abnormal inflammatory response of the lung to noxious particles or gases
COPD
3rd leading cause of death in the US and the 6th leading cause of death worldwide
COPD
Chronic bronchitis plus emphysema
COPD
Air trapping
COPD risk factors (8)
Tobacco smoke
Occupational dusts and chemicals
Indoor air pollution from biomass fuel used for cooking and heating
Outdoor air pollution
Any factor that affects lung growth during gestation and childhood
Genetic susceptibilities
Which genetic mutation is associated with the development of emphysema even in nonsmokers?
Inherited mutation in the alpha-1 antitrypsin gene
Inherited mutation in the alpha-1 antitrypsin gene results in the development of emphysema even in nonsmokers
Genetic susceptibilities of COPD
Hypersecretion of mucus &chronic productive cough that lasts at least 3 months of the year & for at least 2 consecutive years
Chronic Bronchitis
Chronic Bronchitis (4)
Inspired irritants increase mucous production, size & number of mucous glands, & bronchial edema; mucus is thicker than normal
Hypertrophied bronchial smooth muscle
Hypoxemia & hypercapnia
Airways collapse early in expiration, trapping gas in the lung
Chronic Bronchitis Clinical manifestations (5)
Decreased exercise tolerance
Wheezing and shortness of breath
Productive cough (“smoker’s cough”) becomes copious
Polycythemia
Decreased FEV1
Chronic Bronchitis TX (8)
Smoking cessation: Disease progression can be halted
Bronchodilators
Expectorants
Chest physical therapy
Antibiotics
Steroids
Mechanical ventilation, if needed
Oxygen therapy
Chronic Bronchitis teaching (4)
Nutritional counseling
Respiratory hygiene
Recognition of the early signs of infection
Techniques that relieve dyspnea, such as pursed-lip breathing
Abnormal permanent enlargement of thegas-exchange airways accompanied by the destruction of the alveolar walls w/out obvious fibrosis
Emphysema
Loss of elastic recoil
Emphysema
Inherited deficiency of the enzyme α1-antitrypsin
Primary emphysema